1. "1. Quazi S. Vaccine in response to COVID-19: Recent developments, challenges, and a way out. BBRJ. 2021; 5(2):105-109. doi 10.4103/bbrj.bbrj_166_20.
2. 2. Franchini M, Liumbruno GM, Pezzo M. COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021; 107(2): 173-180. doi: 10.1111/ejh.13665.
3. 3. Aleem A, Nadeem AJ. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. PMID: 34033367.
4. 4. Rahimi FS, Afaghi S, Esmaeili Tarki F, Goudarzi K, Malekpour Alamdari N. Viral Outbreaks of SARS-CoV1, SARS-CoV2, MERS-CoV, Influenza H1N1, and Ebola in 21st Century; A Comparative Review of the Pathogenesis and Clinical Characteristics. Sch Med Stud J. 2020;2(3):1-8.
5. 5. Basiri, N, M. Koushki, Study of Vaccine Production Abroad and Scientific and Research Challenges of COVID-19 Vaccine Production in Iran. Annals of RSCB. 2021;25(4):17249-56.